Nivolumab, anti-programmed death-1 (PD-1) monoclonal antibody immunotherapy: Role in advanced cancers
Author:
Publisher
Informa UK Limited
Subject
Pharmacology,Immunology,Immunology and Allergy
Link
http://www.tandfonline.com/doi/pdf/10.1080/21645515.2016.1175694
Reference90 articles.
1. The biography of the immune system and the control of cancer: from St Peregrine to contemporary vaccination strategies
2. Cancer immunotherapy: The past, the present and the future
3. Cancer Immunotherapy: Past Progress and Future Directions
4. Oncology Meets Immunology: The Cancer-Immunity Cycle
5. Cancer Immunotherapy Comes of Age
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring potential roles of long non-coding RNAs in cancer immunotherapy: a comprehensive review;Frontiers in Immunology;2024-08-27
2. Gaussian accelerated molecular dynamics simulations facilitate prediction of the permeability of cyclic peptides;PLOS ONE;2024-04-23
3. Systematic Review on the Effectiveness and Outcomes of Nivolumab Treatment Schemes in Advanced and Metastatic Cervical Cancer;Diseases;2024-04-15
4. Towards a better understanding of light-glucose induced modifications on the structure and biological activity of formulated Nivolumab;International Journal of Pharmaceutics;2024-04
5. Novel Immunotherapy Approaches in Colorectal Cancer;Interdisciplinary Cancer Research;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3